Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mereo BioPharma (MREO) EBIT Margin (2023 - 2025)

Historic EBIT Margin for Mereo BioPharma (MREO) over the last 2 years, with Q2 2025 value amounting to 2099.8%.

  • Mereo BioPharma's EBIT Margin changed N/A to 2099.8% in Q2 2025 from the same period last year, while for Sep 2025 it was 14684.69%, marking a year-over-year decrease of 107631900.0%. This contributed to the annual value of 284.16% for FY2023, which is N/A changed from last year.
  • Latest data reveals that Mereo BioPharma reported EBIT Margin of 2099.8% as of Q2 2025.
  • Over the past 5 years, Mereo BioPharma's EBIT Margin peaked at 6223.33% during Q1 2025, and registered a low of 2099.8% during Q2 2025.